Profile data is unavailable for this security.
About the company
Bright Green Corporation is a producer and manufacturer of plant-based drugs and active pharmaceutical ingredients (APIs). The Company specializes in the research, production, distribution, and advancement of plant-based drugs and APIs, including psilocybin, psilocyn, peyote, and opium poppy. It plans to focus on the development of cannabis strains and sales of cannabis and hemp products with high contents of cannabinol (CBN) and cannabigerol (CBG). It also plans to cultivate cannabis and focus on the production of dried flowers, and oils and marijuana extracts. In addition to cannabis, it also has a separate area for controlled substance cactus cultivation, and a separate controlled area for mushroom propagation. It is in the process of completing construction of the 22-acre existing greenhouse to comply with the requirements for Schedule I and Schedule II plant-based drugs. It also plans to construct two new 57-acre greenhouses, one each on the Candelaria property and Azuz property.
- Revenue in USD (TTM)0.00
- Net income in USD-9.03m
- Incorporated2019
- Employees5.00
- LocationBright Green Corp401 East Las Olas Blvd., Suite 1400FT LAUDERDALE 33301United StatesUSA
- Phone+1 (201) 370-1140
- Fax+1 (302) 636-5454
- Websitehttps://brightgreen.us/
More ▼
Mergers & acquisitions
| Acquired company | BGXX:PKC since announced | Transaction value |
|---|---|---|
| C2 Wellness Corp | -65.83% | 1.20m |
Data delayed at least 15 minutes, as of Nov 25 2024 20:56 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NDT Pharmaceuticals Inc | -100.00bn | -100.00bn | 9.51m | 1.00 | -- | 0.0531 | -- | -- | -- | -- | -- | 1.12 | -- | -- | -- | -- | -- | -164.47 | -- | -452.47 | -- | -- | -- | -6,891.36 | -- | -- | 0.00 | -- | -100.00 | -- | 87.56 | -- | -- | -- |
| Bio Essence Corp | 593.21k | -1.02m | 9.88m | 12.00 | -- | -- | -- | 16.66 | -0.0278 | -0.0156 | 0.0158 | -0.0458 | 0.3305 | -- | 21.20 | -- | -57.09 | -46.10 | -- | -- | 25.05 | 33.89 | -172.74 | -111.21 | -- | -59.99 | 7.03 | -- | -11.27 | -10.94 | -52.03 | -- | -48.19 | -- |
| Aytu Biopharma Inc | 75.48m | -6.63m | 10.02m | 99.00 | -- | 0.3361 | 11.96 | 0.1328 | -1.26 | -1.22 | 11.72 | 4.85 | 0.6069 | 1.92 | 2.85 | 762,393.90 | -5.33 | -27.76 | -10.87 | -46.03 | 68.61 | 58.88 | -8.79 | -56.45 | 0.80 | -- | 0.357 | -- | -24.58 | 61.73 | 7.08 | -- | -- | -- |
| Integrated BioPharma, Inc. | 51.02m | 430.00k | 10.19m | 147.00 | 25.91 | 0.5216 | 13.19 | 0.1997 | 0.0131 | 0.0131 | 1.63 | 0.6488 | 1.93 | 4.29 | 11.92 | 347,068.00 | 1.63 | 13.15 | 2.12 | 19.97 | 8.67 | 11.22 | 0.8428 | 5.87 | 1.18 | -- | 0.00 | -- | -0.7006 | 0.1357 | 806.25 | -41.77 | 5.96 | -- |
| Immunoprecise Antibodies Ltd | 17.23m | -19.75m | 10.84m | 102.00 | -- | 0.4368 | -- | 0.629 | -0.7462 | -0.7462 | 0.6589 | 0.8608 | 0.3546 | 6.12 | 6.16 | -- | -40.63 | -26.70 | -46.68 | -30.31 | 48.21 | 56.13 | -114.58 | -85.72 | 0.8189 | -134.72 | 0.3289 | -- | 18.65 | 17.54 | -2.32 | -- | 16.71 | -- |
| Talphera Inc | 281.00k | -15.64m | 11.81m | 15.00 | -- | 1.23 | -- | 42.03 | -0.6786 | -0.6792 | 0.0118 | 0.5662 | 0.0127 | -- | -- | 18,733.33 | -70.64 | -22.60 | -82.44 | -28.55 | -- | -- | -5,565.48 | -714.87 | -- | -- | 0.00 | -- | -- | -21.26 | -119.16 | -- | -34.33 | -- |
| Cumberland Pharmaceuticals, Inc. | 36.79m | -10.87m | 14.88m | 91.00 | -- | 0.5994 | -- | 0.4046 | -0.7692 | -0.7692 | 2.61 | 1.77 | 0.4472 | 0.9316 | 3.07 | 404,235.70 | -13.18 | -7.03 | -20.32 | -9.52 | 83.31 | 79.95 | -29.48 | -17.64 | 0.9884 | -29.44 | 0.3967 | -- | -5.85 | 6.15 | -12.73 | -- | -36.17 | -- |
| Bright Green Corp | 0.00 | -9.03m | 15.33m | 5.00 | -- | 1.71 | -- | -- | -0.0485 | -0.0485 | 0.00 | 0.0467 | 0.00 | -- | -- | 0.00 | -44.63 | -- | -73.32 | -- | -- | -- | -- | -- | -- | -13,031.30 | 0.0828 | -- | -- | -- | 52.54 | -- | -- | -- |
| TherapeuticsMD Inc | 1.60m | -3.97m | 15.80m | 1.00 | -- | 0.5831 | -- | 9.90 | -0.3499 | -0.291 | 0.1399 | 2.35 | 0.0355 | -- | 0.4944 | 1,596,000.00 | -8.81 | -53.35 | -11.41 | -111.61 | 31.45 | 86.67 | -248.56 | -236.57 | -- | -- | 0.00 | -- | -98.14 | -39.53 | -816.85 | -- | -- | -- |
| Cara Therapeutics Inc | 8.69m | -95.53m | 16.74m | 55.00 | -- | 23.67 | -- | 1.93 | -1.75 | -1.75 | 0.1589 | 0.0129 | 0.1042 | 0.6312 | 4.59 | 157,927.30 | -114.63 | -35.76 | -142.84 | -40.82 | 56.44 | -- | -1,099.76 | -162.10 | 4.71 | -- | 0.00 | -- | -49.92 | 9.26 | -38.65 | -- | 100.66 | -- |
| Gelteq Ltd | 0.00 | -1.54m | 17.27m | -- | -- | 1.22 | -- | -- | -0.1609 | -0.1609 | 0.00 | 1.50 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 1.38 | -32.41 | 0.0605 | -- | -- | -- | -72.77 | -- | -- | -- |
| Marinus Pharmaceuticals Inc | 31.47m | -140.49m | 17.90m | 165.00 | -- | -- | -- | 0.5689 | -2.47 | -2.47 | 0.5524 | -1.21 | 0.238 | 0.6542 | 7.75 | 190,703.00 | -106.26 | -49.64 | -140.93 | -57.76 | 90.17 | -- | -446.49 | -518.96 | 1.47 | -10.06 | -- | -- | 21.63 | -- | -613.59 | -- | 7.47 | -- |
| BioXcel Therapeutics Inc | 2.28m | -71.00m | 20.74m | 74.00 | -- | -- | -- | 9.11 | -2.15 | -2.15 | 0.0637 | -2.02 | 0.0305 | 1.14 | 6.17 | 30,756.76 | -95.08 | -74.57 | -168.28 | -84.06 | 10.98 | -- | -3,119.33 | -32,300.74 | 1.81 | -6.54 | 5.55 | -- | 268.00 | -- | -8.02 | -- | -43.26 | -- |
| Cyclo Therapeutics Inc | 870.72k | -24.80m | 20.95m | 8.00 | -- | -- | -- | 24.06 | -0.9232 | -0.9232 | 0.0322 | -0.4683 | 0.1605 | 0.342 | 3.54 | 108,840.00 | -457.10 | -132.22 | -- | -215.17 | 91.24 | 90.37 | -2,848.18 | -1,114.04 | 0.1614 | -- | -- | -- | -21.76 | 1.25 | -29.81 | -- | -3.95 | -- |
| China Health Industries Holdings, Inc. | 95.95k | -1.36m | 21.30m | 32.00 | -- | -- | -- | 221.99 | -0.0208 | -0.0208 | 0.0015 | -0.0366 | 0.0037 | 0.5035 | 20.57 | 2,998.44 | -5.18 | 3.04 | -6.89 | 3.66 | -5.34 | 69.55 | -1,419.49 | 28.61 | 0.0377 | -- | 1.76 | -- | 41,225.93 | -55.72 | -15.49 | -- | -- | -- |
Data as of Nov 25 2024. Currency figures normalised to Bright Green Corp's reporting currency: US Dollar USD
0.12%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Investment Management LLCas of 30 Jun 2024 | 100.15k | 0.05% |
| XTX Markets LLCas of 30 Sep 2024 | 33.10k | 0.02% |
| SSgA Funds Management, Inc.as of 30 Sep 2024 | 18.20k | 0.01% |
| IBI Mutual Funds Management (1978) Ltd.as of 31 Jul 2024 | 17.49k | 0.01% |
| Lord, Abbett & Co. LLCas of 30 Jun 2024 | 16.20k | 0.01% |
| Pennsylvania State Employees' Retirement Systemas of 31 Dec 2023 | 11.53k | 0.01% |
| AllianceBernstein LPas of 30 Jun 2024 | 9.90k | 0.01% |
| Morgan Stanley Investment Management, Inc.as of 30 Jun 2024 | 9.18k | 0.01% |
| Mackenzie Financial Corp.as of 31 Mar 2024 | 3.66k | 0.00% |
| T. Rowe Price International Ltd.as of 30 Jun 2024 | 2.96k | 0.00% |
More ▼
Data from 31 Dec 2023 - 30 Sep 2024Source: FactSet Research Systems Inc.
